Goodwin Procter advised Qilu Pharmaceutical on the deal. Qilu Pharmaceutical, one of the leading pharmaceutical companies in China (“Qilu”), announced its exclusive licensing agreement and strategic partnership […]
Qilu Pharmaceutical’s Licensing Agreement and Partnership with Arbutus Biopharma Corporation
FTC Solar’s Initial Public Offering
Goodwin Procter LLP advised the underwriters on the deal. FTC Solar, Inc. (“FTC”) announced the pricing of its initial public offering of 19,840,000 shares of its […]